Key facts
- It has raised $100.0M; the latest was Early Stage VC ($100.0M) in Jul 2025.
- Notable investors include Thrive Capital, Greenoaks Capital Partners, Sabrina Hahn.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Nudge (Healthcare Technology Systems)
- ·The full record, as it builds
Funding rounds
No funding rounds for Nudge (Healthcare Technology Systems) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Nudge (Healthcare Technology Systems)
Developer of an ultrasound phased array device designed to develop the technology for interfacing with the brain to improve people's lives. The company specializes in non-invasive neuromodulation technology, integrated into a helmet structure compatible with MRI machines, and builds on existing scientific literature that demonstrates the potential of low-intensity ultrasound to modulate brain regions, helping people to improve their lives through non-invasive, ultrasound-based devices.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2024
- Employees
- 24
- Website
- nudge.com/
- Ownership
- Privately Held (backing)
Nudge (Healthcare Technology Systems) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nudge (Healthcare Technology Systems) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nudge (Healthcare Technology Systems) in its N-PORT filings yet. We sweep new filings monthly.